Saturday, September 23, 2023
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Cuba’s Nasalferon drug against Covid-19 is considered safe

Havana, May 4 (Prensa Latina) The Center for Genetic Engineering and Biotechnology (CIGB) ratified that Nasalferon, a drug developed in Cuba against Covid-19, is safe and well tolerated.

The drug, which strengthens the immune system, and is administered nasally in a prophylactic scheme with a drop in each nostril twice a day for 10 days, can reduce the risk of severe symptoms in people with Covid-19,” the CIGB wrote on its Twitter account.

This preparation is an antiviral, immunomodulatory and prophylactic product, and it can be used against different acute respiratory diseases.

It is a formulation of recombinant human Alpha-2b-interferon for nasal administration, whose immunomodulatory and antiviral properties prevent the replication of the SARS-CoV-2 coronavirus, which causes Covid-19, and strengthen the immune system, the text added.

Of proven safety, this drug had a leading role when the Delta strain of the coronavirus was found in Cuba and it was necessary to increase the population’s defensive response.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.